AV
About
AVM is the wholly-owned venture capital organization within Astellas, dedicated to supporting pre-clinical, cutting-edge science that can bring VALUE to patients. For over 15 years, AVM has provided equity investments to private, early-stage companies developing therapeutic programs and platform technologies, helping them to advance their innovations faster. AVM is a strategic investor, making investments in science that will enhance the current Astellas R&D pipeline or that could catalyze new directions in discovery research.
Sector Focus
Life Sciences
Digital Twin
Therapeutics
Genetics
Series Focus
Pre-Seed
Series C
Portfolio
Investment Activity
No timeline data for this period
Score Breakdown
31Deal Activity
18Track Record
24Visibility
5Profile
85Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is Astellas Venture Management?
AVM is the wholly-owned venture capital organization within Astellas, dedicated to supporting pre-clinical, cutting-edge science that can bring VALUE to patients. For over 15 years, AVM has provided equity investments to private, early-stage companies developing therapeutic programs and platform technologies, helping them to advance their innovations faster. AVM is a strategic investor, making inv…
What kind of firm is Astellas Venture Management?
Astellas Venture Management is a Corporate Venture Capital.
Where is Astellas Venture Management based?
Astellas Venture Management is based in United States.
What sectors does Astellas Venture Management focus on?
Astellas Venture Management focuses on Life Sciences, Digital Twin, Therapeutics, Genetics.
Similar Investors